ENDRA Life Sciences (NDRA) Non-Current Assets (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Non-Current Assets of $2.9 million for Q1 2026, up 192.97% year-over-year from $990392.0 in Q1 2025, and up 0.54% quarter-over-quarter from $2.9 million in Q4 2025.
ENDRA Life Sciences (NDRA) Non-Current Assets (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Non-Current Assets for 11 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets rose 192.97% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $6.2 million (up 315.59% YoY), while the FY2025 annual figure was $2.9 million, up 201.06% from the prior year.
- Non-Current Assets advanced to $2.9 million in Q1 2026 per NDRA's latest filing, from $2.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.9 million in Q4 2022 and bottomed at -$4.7 million in Q3 2024.
- Historically, Non-Current Assets has averaged $1.2 million across 5 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 398.99% — and 2024, when it slumped 492.79%.
- ENDRA Life Sciences' Non-Current Assets stood at $3.9 million in 2022, then slipped by 4.45% to $3.7 million in 2023, then plunged by 176.74% to -$2.9 million in 2024, then surged by 201.06% to $2.9 million in 2025, then advanced by 0.54% to $2.9 million in 2026.
- Business Quant data shows NDRA's Non-Current Assets at $2.9 million in Q1 2026, $2.9 million in Q4 2025, and -$557346.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1.93 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 8.30 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.66 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 962.59 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 3.82 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 2.32 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 14.10 Bn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.90 Mn |
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | -557,346.00 |
| Jun 30, 2025 | 954,788.00 |
| Mar 31, 2025 | 990,392.00 |
| Dec 31, 2024 | -2.86 Mn |
| Sep 30, 2024 | -4.73 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.79 Mn |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 1.14 Mn |
| Dec 31, 2022 | 3.89 Mn |
| Sep 30, 2022 | 778,054.00 |
| Jun 30, 2022 | 821,785.00 |
| Mar 31, 2022 | 817,665.00 |
| Dec 31, 2021 | 780,529.00 |
| Sep 30, 2021 | 844,073.00 |
| Jun 30, 2021 | 899,592.00 |